인쇄하기
취소

Growing demand over Relenza

Published: 2009-09-04 06:58:00
Updated: 2009-09-04 06:58:00
Due to growing concerns over the rapidly spreading H1N1 flu virus, many pharmacies are making efforts to secure a sufficient supply of treatment drugs, including GlaxoSmithKline’s antiviral drug Relenza, for their stockpiles.

Industry watchers said the H1N1 flu virus scare will sent the demand for Relenza soaring since the nation's fourth death was reported on September 2.

On August 25, t...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.